For: | Chandra A, Johri A. A Peek into Pandora’s Box: COVID-19 and Neurodegeneration. Brain Sciences 2022;12:190. [DOI: 10.3390/brainsci12020190] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Redenšek Trampuž S, Vogrinc D, Goričar K, Dolžan V. Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature. Front Mol Neurosci 2023;16. [DOI: 10.3389/fnmol.2023.1123955] [Reference Citation Analysis] |
2 | Fenton C, Lee A. Antidepressants with anti-inflammatory properties may be useful in long COVID depression. Drugs Ther Perspect 2023;39:65-70. [PMID: 36532316 DOI: 10.1007/s40267-022-00975-x] [Reference Citation Analysis] |
3 | Stoyanov GS, Stoyanov D, Ivanov M, Tonchev AB, Popov H, Petkova L. COVID-19-Associated Encephalopathy (COVEP): Basic Aspects of Neuropathology. Encyclopedia 2022;2:1773-1789. [DOI: 10.3390/encyclopedia2040122] [Reference Citation Analysis] |
4 | Sesti-Costa R, Negrão CVZ, Shimizu JF, Nagai A, Tavares RSN, Adamoski D, Costa W, Fontoura MA, da Silva TJ, de Barros A, Girasole A, de Carvalho M, Teixeira VC, Ambrosio ALB, Granja F, Proença-Módena JL, Marques RE, Dias SMG. UV 254 nm is more efficient than UV 222 nm in inactivating SARS-CoV-2 present in human saliva. Photodiagnosis Photodyn Ther 2022;39:103015. [PMID: 35843562 DOI: 10.1016/j.pdpdt.2022.103015] [Reference Citation Analysis] |